학술논문
Outcomes and Costs in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving Front-Line Versus Delayed Caplacizumab: A US Hospital Database Study
Document Type
Article
Author
Source
In: Clinical and Applied Thrombosis/Hemostasis . (Clinical and Applied Thrombosis/Hemostasis, January-December 2024, 30)
Subject
Language
English
ISSN
19382723
10760296
10760296